CytoMed Therapeutics Ltd
GDTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873093
In the last 90 days, CytoMed Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 3 institutions reported holding it in 13F filings for Q2 2026, worth $12.2K in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding CytoMed Therapeutics Ltd changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 2 | 2 | 0 |
| Shares | 31.7K | 45.3K | +13.6K (+42.8%) |
| Value | $70.3K | $98.5K | +$28.2K (+40.1%) |
New holders (0)
Institutions that held CytoMed Therapeutics Ltd at the end of Q2 2025 but not at the end of Q1 2025.
None.
Sold out (0)
Institutions that held CytoMed Therapeutics Ltd at the end of Q1 2025 and filed for Q2 2025 without it.
None.